Illustration: Spectral-Design / Shutterstock.com
The US Patent and Trademark Office has issued a patent to Israeli biotechnology company BrainStorm Cell Therapeutics, which covers stem cell technology that can be used in the treatment of neurodegenerative diseases such as Parkinson’s and Alzheimer’s.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Stem cells, BrainStorm Cell Therapeutics, USPTO, Parkinson’s, Alzheimer’s